HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Embryonal rhabdomyosarcoma of the caruncle in a 4 year-old boy: case report.

Abstract
Rhabdomyosarcoma is a rare tumor, with an annual incidence of 4.3 cases per million children. Even thought, it is the most common soft tissue sarcoma in childhood, with a mean age of 6 to 8 years at diagnosis. A 4 year-old boy presented with a history of a fast growing (1-month) nodular lesion in the caruncle of his left eye. Slit lamp examination showed a vascularized solid nodular lesion in the semilunar fold. The lesion was surgically removed obtaining infiltrated edges with tumoral cells. A second surgery was performed with free tumour edges. The diagnosis of embryonal rhabdomyosarcoma, botryoid type, of intermediate differentiation was made. The treatment for botryoid rhabdomyosarcoma is basically surgical with the combined use of adjuvant polychemotherapy. In adolescent or adult patients (not in infants where growth bone disturbances can occur) external beam radiotherapy can be combined with chemotherapy. Rhabdomyosarcomas of the conjunctiva without orbital extension are rarely reported. We presented a case of a child with a rare tumor which we had a high suspicion of malignancy and early diagnosis and treatment and child is free of systemic disease 6 and half years later. Our research group believes that the key in these tumors is the high index of suspicion and early treatment.
AuthorsMaria Del Carmen Mendez, Yerena Muiños, Gonzalo Blanco, Maria Antonia Saornil, Ciro García-Alvarez, Jose Luis Sarasa, Carmen Valbuena
JournalArquivos brasileiros de oftalmologia (Arq Bras Oftalmol) 2012 May-Jun Vol. 75 Issue 3 Pg. 207-9 ISSN: 1678-2925 [Electronic] Brazil
PMID22872206 (Publication Type: Case Reports, Journal Article)
Topics
  • Child
  • Eye Neoplasms (pathology, surgery)
  • Humans
  • Male
  • Rhabdomyosarcoma, Embryonal (pathology, surgery)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: